| Literature DB >> 34054352 |
Viktor Dubovoy1,2, Primit Desai3, Zhigang Hao1, Chi-Yuan Cheng1, Gaurav Verma4, Lukasz Wojtas4, Tatiana V Brinzari1, Jeffrey M Boyd3, Shengqian Ma4, Tewodros Asefa2,5, Long Pan1.
Abstract
The synthesis, crystal structure, and antimicrobial efficacy are reported for a novel material comprising a 1:2 ratio of chlorhexidine (CHX) to N-cyclohexylsulfamate (i.e., artificial sweetener known as cyclamate). The chemical structure is unambiguously identified by incorporating a combination of single-crystal X-ray diffraction (SC-XRD), electrospray ionization mass spectrometry (ESI-MS), 1H nuclear magnetic resonance (NMR) spectroscopy, correlation spectroscopy (COSY), and attenuated total reflection Fourier-transform infrared spectroscopy (ATR-FTIR). The new material: 1) is amongst only several reported structures identified to date incorporating the vital chlorhexidine antimicrobial drug; 2) exhibits broad spectrum antimicrobial activity at concentrations less than 15 μg/mL; and 3) provides a unique delivery method for the essential active pharmaceutical ingredient (API). Furthermore, substitution of inactive gluconate with bioactive cyclamate counterion potentially provides the additional benefit of improving the taste profile of chlorhexidine.Entities:
Keywords: Chlorhexidine; N-cyclohexylfulfamate; antimicrobial agent; cyclamate
Year: 2020 PMID: 34054352 PMCID: PMC8159181 DOI: 10.1021/acs.cgd.0c00107
Source DB: PubMed Journal: Cryst Growth Des ISSN: 1528-7483 Impact factor: 4.076